These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7793876)

  • 41. In vitro activity and killing effect of DX-8739, a new carbapenem, compared with those of meropenem and imipenem against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    Antimicrob Agents Chemother; 1995 Mar; 39(3):731-4. PubMed ID: 7793881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
    Shen JL; Fang YP
    Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response of chemostat cultures of Pseudomonas aeruginosa to carbapenems and other beta-lactams.
    Wu PJ; Livermore DM
    J Antimicrob Chemother; 1990 Jun; 25(6):891-902. PubMed ID: 2115037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
    Tasaka K; Ishida A; Chinzei T
    Jpn J Antibiot; 2002 Apr; 55(2):181-6. PubMed ID: 12071095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
    Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
    J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
    J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.
    Sakyo S; Tomita H; Tanimoto K; Fujimoto S; Ike Y
    J Antibiot (Tokyo); 2006 Apr; 59(4):220-8. PubMed ID: 16830889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular typing and resistance mechanisms of carbapenem resistant Pseudomonas aeruginosa isolated from a Chinese surgical intensive care unit.
    Yi M; Wang P; Liu Y
    Chin Med J (Engl); 2014; 127(6):1071-6. PubMed ID: 24622437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to a new catecholic cephem, BO-1341, in Pseudomonas aeruginosa PAO.
    Hazumi N; Matsuda K; Sanada M; Ohtake N; Tanaka N
    J Antimicrob Chemother; 1992 Mar; 29(3):287-97. PubMed ID: 1592698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa.
    Tsuchimochi N; Takuma T; Shimono N; Nagasaki Y; Uchida Y; Harada M
    J Infect Chemother; 2008 Apr; 14(2):99-104. PubMed ID: 18622671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Okamoto K; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    Hiraishi T; Miyata A; Takata T; Araake M; Ogawa H; Gotoh N; Nishino T
    Jpn J Antibiot; 2002 Feb; 55(1):67-76. PubMed ID: 11977922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.
    Sanders CC; Sanders WE; Thomson KS; Iaconis JP
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():187-96. PubMed ID: 2808207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.
    Cornaglia G; Mazzariol A; Lauretti L; Rossolini GM; Fontana R
    Clin Infect Dis; 2000 Nov; 31(5):1119-25. PubMed ID: 11073738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
    Bou G; Cerveró G; Domínguez MA; Quereda C; Martínez-Beltrán J
    J Clin Microbiol; 2000 Sep; 38(9):3299-305. PubMed ID: 10970374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
    Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
    Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antimicrobial activities and mechanisms of carbapenem resistance in clinical isolates of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp].
    Sugino Y; Iinuma Y; Nada T; Tawada Y; Amano H; Nakamura T; Hasegawa Y; Shimokata K; Shibata N; Arakawa Y
    Kansenshogaku Zasshi; 2001 Aug; 75(8):662-70. PubMed ID: 11558128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
    Yang Y; Bhachech N; Bush K
    J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.